Patents by Inventor Valerie Martelange

Valerie Martelange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor associated amino acids and uses therefor
    Patent number: 8247379
    Abstract: The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: August 21, 2012
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Valerie Martelange, De Smet Charles, Thierry Boon-Falleur
  • TUMOR ASSOCIATED AMINO ACIDS AND USES THEREFOR
    Publication number: 20080299078
    Abstract: The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 4, 2008
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Valerie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Patent number: 7411042
    Abstract: The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: August 12, 2008
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Valérie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Patent number: 7001999
    Abstract: The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: February 21, 2006
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Valerie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Publication number: 20060024742
    Abstract: The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.
    Type: Application
    Filed: September 30, 2005
    Publication date: February 2, 2006
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Valerie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Publication number: 20020115142
    Abstract: The invention describes sdp3.8 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdp3.8 gene product.
    Type: Application
    Filed: August 7, 2001
    Publication date: August 22, 2002
    Inventors: Valerie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Patent number: 6303756
    Abstract: The invention describes sdp3.8 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdp3.8 gene product.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: October 16, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Valérie Martelange, Charles De Smet, Thierry Boon-Falleur
  • Tumor associated nucleic acids and uses therefor
    Patent number: 6245525
    Abstract: The invention describes sdp3.8 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdp3.8 gene product.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: June 12, 2001
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Valérie Martelange, Charles De Smet, Thierry Boon-Falleur